Revance Therapeutics (NASDAQ:RVNC) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other research analysts have also weighed in on the company. HC Wainwright reissued a “neutral” rating and set a $6.60 price target on […]
More Stories
Apple Inc. (NASDAQ:AAPL) Position Lifted by McBroom & Associates LLC
McBroom & Associates LLC boosted its position in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 2.8% in the...
Apple Inc. (NASDAQ:AAPL) Shares Acquired by Essex Financial Services Inc.
Essex Financial Services Inc. raised its position in Apple Inc. (NASDAQ:AAPL – Free Report) by 2.6% during the fourth quarter,...
Atlantic Edge Private Wealth Management LLC Purchases 418 Shares of Apple Inc. (NASDAQ:AAPL)
Atlantic Edge Private Wealth Management LLC lifted its position in Apple Inc. (NASDAQ:AAPL – Free Report) by 0.9% in the...
First National Corp MA ADV Sells 91 Shares of Apple Inc. (NASDAQ:AAPL)
First National Corp MA ADV cut its position in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 0.1% during...
JPMorgan Chase & Co. Sells 23,110 Shares of Avantis U.S. Large Cap Value ETF (NYSEARCA:AVLV)
JPMorgan Chase & Co. lowered its position in Avantis U.S. Large Cap Value ETF (NYSEARCA:AVLV – Free Report) by 12.0%...
Sylvamo Co. (NYSE:SLVM) Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. grew its position in shares of Sylvamo Co. (NYSE:SLVM – Free Report) by 62.0% in the...